DRUG · Unmapped registry intervention
Adebrelimab
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
NCT06177925
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Carboplatin/Cisplatin
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Etoposide
Normalized identity: etoposideView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
Radiation therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Thoracic Neoplasmsunresolved
Neoplasms by Siteunresolved
Neoplasmsunresolved
Lung Diseasesunresolved
Respiratory Tract Diseasesunresolved
Bronchial Neoplasmsunresolved
Lung Neoplasmsverified · MONDO: lung neoplasm
Interventions
Sponsors & collaborators
Nanfang Hospital, Southern Medical Universitylead sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06177925 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.